Wall Street RegretsThe regret calculator.

What if you'd held ANIP?

A $1,000 investment in ANI Pharmaceuticals, Inc. (ANIP) at the month-end close of 2000-05 would be worth $308 at the close of 2026-08 — -69.2% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $5,426.

$1,000 since 2000$308Total return-69.2%Multiple0.31×CAGR-4.4%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$308Gain+$-692 (-69.2%)Multiple0.3×CAGR-4.4%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$3082001$2892002$2552003$6472004$5232005$3952006$5942007$7822008$5732009$2,1672010$1,4952011$1,3212012$4,3342013$10,5722014$3,8852015$1,3842016$1,7292017$1,2872018$1,2112019$1,7332020$1,2652021$2,6872022$1,6932023$1,9392024$1,4152025$1,4112026$988

    Every year, $1,000 from 2000

    YearValue of $1,000Year return
    2000$1,000
    2001$1,133+13.3%
    2002$447-60.6%
    2003$552+23.6%
    2004$731+32.4%
    2005$487-33.4%
    2006$369-24.1%
    2007$504+36.5%
    2008$133-73.5%
    2009$193+45.0%
    2010$219+13.1%
    2011$66.67-69.5%
    2012$27.33-59.0%
    2013$74.37+172.1%
    2014$209+180.8%
    2015$167-20.0%
    2016$225+34.3%
    2017$239+6.3%
    2018$167-30.1%
    2019$228+37.0%
    2020$108-52.9%
    2021$171+58.7%
    2022$149-12.7%
    2023$204+37.1%
    2024$205+0.3%
    2025$292+42.8%
    2026$289-1.2%

    Best and worst month-end to buy

    The best single month-end close to have bought ANIP was 2013-06 ($6.00): $1,000 then is $13,003 today. The worst was 2000-08 ($366): $1,000 then is $213.

    FAQ

    What would $1,000 in ANIP be worth today?

    A $1,000 investment in ANI Pharmaceuticals, Inc. (ANIP) at the start of 2000 would be worth about $308 today, a total return of -69.2%. Dividends are reinvested in these figures.

    What were the best and worst years for ANIP?

    ANI Pharmaceuticals, Inc. (ANIP)'s strongest calendar year since 2000 was 2014, a +180.8% return — $1,000 held through that year became about $2,808 by year-end. Its weakest year was 2008, at -73.5%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in ANIP have grown?

    Investing $100 at the end of every month since 2000-05 would have grown to about $54,355 on $31,600 invested.

    Did ANIP beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $5,426. ANIP trailed the S&P 500 by +94.3% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    ANI Pharmaceuticals, Inc. (ANIP) historical total-return data from 2000-05 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.